J. Cyktor

J. Mellors, D. Porter, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Associations of HIV persistence, cigarette smoking, inflammation, and pulmonary dysfunction in people with HIV on antiretroviral therapy

J. Mellors, C. Rinaldo, P. Tien, 2022, Medicine.

Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children

S. Hughes, J. Mellors, J. Coffin, 2021, mBio.

Early Emergence and Long-Term Persistence of HIV-Infected T Cell Clones in Children

S. Hughes, J. Mellors, J. Coffin, 2020, bioRxiv.

Infection tuberculosis Mycobacterium Formation during IL-10 Inhibits Mature Fibrotic Granuloma

G. Beamer, J. Turner, P. Stromberg, 2013 .

Reduction of the HIV-1 reservoir in T cells from persons with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells ex vivo

Michele D. Sobolewski, J. Karn, J. Mellors, 2022, bioRxiv.

Clonal Expansions of CD8+ T Cells with IL-10 Secreting Capacity Occur during Chronic Mycobacterium tuberculosis Infection

G. Beamer, J. Turner, J. Cyktor, 2013, PloS one.

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus–Associated Chronic Inflammation

C. Macatangay, D. Comer, J. Cyktor, 2020 .

Immune Correlates of Resistance and Susceptibility to Tuberculosis

J. Cyktor, 2012 .

Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART

J. Mellors, J. Cyktor, Elizabeth Fyne, 2019, PloS one.

A Simpler and More Sensitive Single-Copy HIV-1 RNA Assay for Quantification of Persistent HIV-1 Viremia in Individuals on Suppressive Antiretroviral Therapy

J. Mellors, K. Shutt, J. Cyktor, 2019, Journal of Clinical Microbiology.

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.

S. Hughes, J. Mellors, J. Coffin, 2019, The Journal of clinical investigation.

HIV-1 in Lymph Nodes is Maintained by Cellular Proliferation During Antiretroviral 1 Therapy 2 3

Patro, S. Hughes, J. Mellors, 2019 .

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

J. Mellors, S. Holmes, R. Bosch, 2022, Frontiers in Cellular and Infection Microbiology.

Discovery and pre-clinical evaluation of antibodies to the NKG2A inhibitory receptor

D. Dimitrov, J. Mellors, J. Cyktor, 2022, bioRxiv.

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

J. Mellors, R. Bosch, R. B. Jones, 2021, AIDS.

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

J. Mellors, R. Bosch, C. Rinaldo, 2017, PLoS pathogens.

HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

J. Mellors, R. Bosch, A. Danesh, 2021, JCI insight.

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.

J. Siliciano, J. Mellors, R. Bosch, 2020, The Journal of infectious diseases.

HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus

S. Hughes, J. Mellors, J. Coffin, 2020, bioRxiv.

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

B. Walker, C. Kovacs, J. Mellors, 2017, PLoS pathogens.

CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection

D. Flaherty, G. Beamer, J. Turner, 2012, European journal of immunology.

HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy

J. Mellors, R. Bosch, A. Danesh, 2020 .

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy

R. Siliciano, J. Mellors, R. Bosch, 2019 .

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Hiv-Associated Chronic Inflammation.

Kaleab Z. Abebe, J. Mellors, C. Rinaldo, 2019, The Journal of infectious diseases.

No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

J. Mellors, R. Bosch, C. Rinaldo, 2019, Journal of acquired immune deficiency syndromes.

Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy.

Kaleab Z. Abebe, J. Mellors, S. Riddler, 2020, Journal of acquired immune deficiency syndromes.

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART

A. Perelson, R. Koup, J. Casazza, 2018, Open forum infectious diseases.

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy

J. Mellors, R. Bosch, J. Eron, 2022, Journal of virus eradication.

Validation of Increased Blood Storage Times with the T-SPOT.TB Assay with T-Cell Xtend Reagent in Individuals with Different Tuberculosis Risk Factors

J. Turner, Shu-Hua Wang, B. Restrepo, 2012, Journal of Clinical Microbiology.

Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens

J. Turner, J. Cyktor, 2011, Infection and Immunity.

CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection

D. Flaherty, G. Beamer, J. Turner, 2012, European Journal of Immunology.

H-2 alleles contribute to antigen 85-specific interferon-gamma responses during Mycobacterium tuberculosis infection.

G. Beamer, J. Turner, J. Cyktor, 2011, Cellular immunology.

A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).

J. Karn, J. Mellors, E. Acosta, 2020, The Journal of infectious diseases.

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

J. Mellors, R. Bosch, R. B. Jones, 2022, AIDS.

HIV-1–infected T cell clones are shared across cerebrospinal fluid and blood during ART

Y. Kluger, S. Farhadian, S Spudich, 2024, JCI insight.

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

S. Little, J. Ananworanich, G. V. Van Zyl, 2024, AIDS.